Panion & Bf Biotech Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 328.716 million compared to TWD 401.292 million a year ago. Operating income was TWD 11.354 million compared to TWD 64.804 million a year ago. Net loss was TWD 7.581 million compared to net income of TWD 46.438 million a year ago. Basic loss per share was TWD 0.1 compared to basic earnings per share of TWD 0.61 a year ago. Diluted loss per share was TWD 0.1 compared to diluted earnings per share of TWD 0.6 a year ago. For the half year, sales was TWD 669.321 million compared to TWD 758.194 million a year ago. Operating income was TWD 26.845 million compared to TWD 116.275 million a year ago. Net loss was TWD 6.873 million compared to net income of TWD 86.074 million a year ago. Basic loss per share was TWD 0.09 compared to basic earnings per share of TWD 1.12 a year ago.